Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

甲状腺癌 肿瘤科 医学 内科学 癌症 甲状腺癌 原发性癌症 甲状腺 数据库 计算机科学
作者
Jianhua Feng,Caixiu Wu,Fei Shen,Wen-song Cai,Bo Xu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
被引量:1
标识
DOI:10.1210/clinem/dgae501
摘要

Abstract Context Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. Objective We aimed to explore the characteristics and outcomes of 2-DTC. Methods We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. Results There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. Conclusion Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wzxxxx发布了新的文献求助10
刚刚
斯文败类应助勤劳傲晴采纳,获得10
1秒前
shilong.yang发布了新的文献求助10
1秒前
momo完成签到,获得积分10
2秒前
wxp_bioinfo完成签到,获得积分10
3秒前
3秒前
桐桐应助wangg采纳,获得10
3秒前
Jun完成签到,获得积分10
4秒前
芝士的酒发布了新的文献求助50
4秒前
5秒前
赘婿应助复杂的问玉采纳,获得30
5秒前
6秒前
6秒前
7秒前
端庄白开水完成签到,获得积分10
7秒前
吕春雨发布了新的文献求助10
7秒前
大个应助wxp_bioinfo采纳,获得10
8秒前
yqq完成签到 ,获得积分10
8秒前
9秒前
10秒前
芝士发布了新的文献求助10
10秒前
橘子发布了新的文献求助10
11秒前
11秒前
11秒前
晨曦发布了新的文献求助10
12秒前
12秒前
kobiy完成签到 ,获得积分10
12秒前
wu完成签到 ,获得积分10
13秒前
蛋泥完成签到,获得积分10
13秒前
顾矜应助mingjie采纳,获得10
14秒前
zhaowenxian发布了新的文献求助10
14秒前
勤劳傲晴发布了新的文献求助10
15秒前
15秒前
橘子完成签到,获得积分10
17秒前
可耐的从安完成签到 ,获得积分10
18秒前
zho应助背后的诺言采纳,获得10
18秒前
粥粥完成签到,获得积分10
18秒前
19秒前
打打应助陈杰采纳,获得10
20秒前
充电宝应助柔弱凡松采纳,获得10
21秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527884
求助须知:如何正确求助?哪些是违规求助? 3108006
关于积分的说明 9287444
捐赠科研通 2805757
什么是DOI,文献DOI怎么找? 1540033
邀请新用户注册赠送积分活动 716904
科研通“疑难数据库(出版商)”最低求助积分说明 709794